
Evaluating the expression of cyclooxygenase-2 enzyme by immunohistochemistry in normal and tumoral tissue before and after neoadjuvant chemoradiotherapy in patients with esophageal cancer in Khorasan Province
Author(s) -
Yousef Jalalabadi,
Alireza Shirazi,
Mohammad-Reza Ghavam–Nasiri,
Seyed Amir Aledavood,
Dariush Sardari,
Bahram Memar,
Soodabeh Shahidsales,
Fatemeh Varshoee-Tabrizi,
Parvane Dehghan,
Hassan Vosughiniya
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.199428
Subject(s) - medicine , immunohistochemistry , esophageal cancer , biopsy , cyclooxygenase , proportional hazards model , chemoradiotherapy , cancer , pathology , oncology , gastroenterology , enzyme , biochemistry , chemistry
Esophageal cancer is the third most common cancer in Iran. Neoadjuvant chemoradiotherapy (NCRT) is the appropriate treatment for esophageal cancer.